SOX4 inhibits GBM cell growth and induces G0/G1 cell cycle arrest through Akt-p53 axis

Jing Zhang1,2, Huawei Jiang3,4, Jiaofang Shao5

  • 1Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education), Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, P R China. jingzh1985@gmail.com.

BMC Neurology
|November 5, 2014
PubMed
Abstract

Insights

SOX4 acts as a tumor suppressor in glioblastoma multiforme (GBM). High SOX4 expression correlates with better prognosis by inhibiting GBM cell growth and inducing cell cycle arrest.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • SOX4 is a crucial transcription factor for vertebrate development.
  • SOX4 overexpression is observed in various cancers, including glioblastoma multiforme (GBM).
  • The precise role and mechanisms of SOX4 in GBM remain largely uncharacterized.

Purpose of the Study:

  • To investigate the functional role of SOX4 in glioblastoma multiforme.
  • To elucidate the underlying molecular mechanisms of SOX4 action in GBM.

Main Methods:

  • Kaplan-Meier survival analysis of primary GBM samples based on SOX4 expression.
  • Generation of SOX4 gain/loss models in GBM cells using the Cre/lox P system.
  • Microarray analysis to identify SOX4-regulated networks and pathways in GBM cells.

Main Results:

  • High SOX4 expression is significantly associated with favorable prognosis in primary GBM.
  • SOX4 suppresses the proliferation of GBM cell lines (LN229, A172G, U87MG).
  • SOX4 exerts its effects through p53-p21 activation, reduced AKT1 phosphorylation, and modulation of Wnt/β-catenin and TGF-β signaling pathways.

Conclusions:

  • SOX4 functions as a tumor suppressor in glioblastoma.
  • SOX4 induces cell cycle arrest and inhibits GBM cell growth.
  • SOX4's tumor-suppressive role involves p53-p21 signaling and affects key cancer-related pathways.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
32.1K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

4.3K
Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
31.0K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.1K